Evogene Ltd. (EVGN)
NASDAQ: EVGN · Real-Time Price · USD
1.250
+0.010 (-1.57%)
At close: Apr 1, 2025, 4:00 PM
1.270
+0.020 (1.57%)
After-hours: Apr 1, 2025, 4:02 PM EDT
Evogene Employees
Evogene had 142 employees as of December 31, 2023. The number of employees increased by 5 or 3.65% compared to the previous year.
Employees
142
Change (1Y)
5
Growth (1Y)
3.65%
Revenue / Employee
$59,937
Profits / Employee
-$116,092
Market Cap
8.34M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
EVGN News
- 26 days ago - Evogene Ltd. (EVGN) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 26 days ago - Evogene Reports Fourth Quarter and Full Year 2024 Financial Results - PRNewsWire
- 26 days ago - Evogene Announces the Appointment of Nir Nimrodi as the New Chairperson of the Board, Effective March 5, 2025 - PRNewsWire
- 5 weeks ago - Evogene Schedules Fourth Quarter 2024 Financial Results Release - PRNewsWire
- 6 weeks ago - AgPlenus Announces Discovery of a New Mode of Action for Fungicides Against Wheat Disease - PRNewsWire
- 4 months ago - Evogene Ltd. (EVGN) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Evogene Reports Third Quarter 2024 Financial Results - PRNewsWire
- 4 months ago - Lavie Bio Advances its Bio-Fungicide LAV321, Targeting Downy Mildew, to Pre-Commercial Stage Following Successful 2024 Field Trial Results - PRNewsWire